Literature DB >> 3028473

Complete sequence and structure of the gene for human adenosine deaminase.

D A Wiginton, D J Kaplan, J C States, A L Akeson, C M Perme, I J Bilyk, A J Vaughn, D L Lattier, J J Hutton.   

Abstract

The nucleotide sequence of the human adenosine deaminase gene was determined. The gene was isolated in a series of overlapping lambda phage clones containing human germ line DNA. A total of 36,741 base pairs were sequenced, including 32,040 base pairs from the transcription initiation site to the polyadenylation site, 3935 base pairs of 5'-flanking DNA, and 766 base pairs of 3'-flanking DNA. The gene contains 12 exons separated by 11 introns. The exons range in size from 62 to 325 base pairs while the introns are 76-15 166 base pairs in size. The area sequenced contains 23 copies of Alu repetitive DNA and a single copy of an "O" family repeat. All but one of these repeat sequences are located in the first three introns or the 5'-flanking region. The apparent promoter region of the gene lacks the "TATA" and "CAAT" sequences often found in eucaryotic promoters and is extremely G/C rich. Contained within this region are areas homologous to other G/C-rich promoters, including six decanucleotide sequences that are highly homologous to sequences identified as functional binding sites for transcription factor Sp1.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3028473     DOI: 10.1021/bi00373a017

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  41 in total

1.  Novel families of interspersed repetitive elements from the human genome.

Authors:  J Jurka
Journal:  Nucleic Acids Res       Date:  1990-01-11       Impact factor: 16.971

2.  Adenosine deaminase (ADA) deficiency due to deletion of the ADA gene promoter and first exon by homologous recombination between two Alu elements.

Authors:  M L Markert; J J Hutton; D A Wiginton; J C States; R E Kaufman
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

3.  Detection of PstI RFLP in human ADA by the polymerase chain reaction.

Authors:  H Ikegami; M Fukuda; Y Kawaguchi; Y Fujioka; T Ogihara
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

4.  Molecular organization of the human Raf-1 promoter region.

Authors:  T W Beck; U Brennscheidt; G Sithanandam; J Cleveland; U R Rapp
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

5.  Xeroderma pigmentosum complementation group C cells remove pyrimidine dimers selectively from the transcribed strand of active genes.

Authors:  J Venema; A van Hoffen; V Karcagi; A T Natarajan; A A van Zeeland; L H Mullenders
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

6.  An STS in the human adenosine deaminase gene (located 20q12-q13.11).

Authors:  B C Freeman; J C States
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

7.  Identification and characterization of nine RFLPs at the adenosine deaminase (ADA) locus.

Authors:  S Tzall; A Ellenbogen; F Eng; R Hirschhorn
Journal:  Am J Hum Genet       Date:  1989-06       Impact factor: 11.025

8.  Characterization of mouse-hamster somatic cell hybrids by PCR: a panel of mouse-specific primers for each chromosome.

Authors:  C Abbott
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

9.  Correct splicing despite mutation of the invariant first nucleotide of a 5' splice site: a possible basis for disparate clinical phenotypes in siblings with adenosine deaminase deficiency.

Authors:  F X Arredondo-Vega; I Santisteban; S Kelly; C M Schlossman; D T Umetsu; M S Hershfield
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

10.  Retroviral vectors encoding ADA regulatory locus control region provide enhanced T-cell-specific transgene expression.

Authors:  Alice T Trinh; Bret G Ball; Erin Weber; Timothy K Gallaher; Zoya Gluzman-Poltorak; French Anderson; Lena A Basile
Journal:  Genet Vaccines Ther       Date:  2009-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.